BPG is committed to discovery and dissemination of knowledge
Homepage
Online Submission
Number of total visits
30632186
Number of visits today
945
Number of downloads
13060174
MEMBERSHIP
Cited by in F6Publishing
For:
Mu X , Zhao Q , Chen W , Zhao Y , Yan Q , Peng R , Zhu J , Yang C , Lan K , Gu X , Wang Y . IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation. Front Oncol 2020;10 :526866. [PMID: 33489865 DOI: 10.3389/fonc.2020.526866 ] [ Cited by in Crossref: 2] [ Cited by in F6Publishing: 3 ] [ Article Influence: 2.0 ] [ Reference Citation Analysis ]
Number
Citing Articles
1
Su Z , Tao X . Current Understanding of IL-37 in Human Health and Disease. Front Immunol 2021;12 :696605. [PMID: 34248996 DOI: 10.3389/fimmu.2021.696605 ] [ Reference Citation Analysis ]
2
Ma C , Ma RJ , Hu K , Zheng QM , Wang YP , Zhang N , Sun ZG . The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. Cancer Cell Int 2022;22 :133. [PMID: 35331234 DOI: 10.1186/s12935-022-02539-5 ] [ Reference Citation Analysis ]
3
Cheng Y , Wang M , Zhou J , Dong H , Wang S , Xu H . The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer. Genes (Basel) 2021;12 :440. [PMID: 33808751 DOI: 10.3390/genes12030440 ] [ Cited by in F6Publishing: 1 ] [ Reference Citation Analysis ]
4
Wang Y , Su X , Zhao M , Xu M , Chen Y , Li Z , Zhuang W . Importance of N6 -methyladenosine RNA modification in lung cancer (Review). Mol Clin Oncol 2021;14 :128. [PMID: 33981432 DOI: 10.3892/mco.2021.2290 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
